Neurochemical and metabolic consequences of elevated cerebrospinal fluid quinolinic acid concentrations in rat brain

Neuroscience Research

Volumn 29, Issue 4, 1997, Pages 303-309

  Maeda, K ^a,b   Kaneda, H ^b   Whetsell, W O ^c   Tamminga, C A ^a,b  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

2 deoxyglucose; Cerebrospinal fluid; Choline acetyltransferase; Local cerebral glucose utilization; Quinolinic acid; Somatostatin

Indexed keywords

CHOLINE ACETYLTRANSFERASE; GLUCOSE; QUINOLINIC ACID; SOMATOSTATIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CEREBROSPINAL FLUID; CORPUS STRIATUM; FRONTAL CORTEX; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HIPPOCAMPUS; LIMBIC SYSTEM; MALE; NEUROCHEMISTRY; NEUROPATHOLOGY; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CHOLINE O-ACETYLTRANSFERASE; GLUCOSE; INJECTIONS, INTRAVENTRICULAR; MALE; QUINOLINIC ACID; RATS; RATS, SPRAGUE-DAWLEY; SOMATOSTATIN;

EID: 0031437364     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(97)00102-8     Document Type: Article

References (36)

1. Abe H., Chihara K., Minamitani N., Iwasaki J., Chiba T., Matsukura S., Fujita T. Stimulation by bombesin of immunoreactive somatostatin release into rat hypophysial portal blood. Endocrinology. 109:1981;229-234.
2. Achim C.L., Heyes M.P., Wiley C.A. Quantification of human immuno-deficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J. Clin. Invest. 91:1993;2769-2775.
3. Balazs R., Hack N., Jorgensen O.S. Stimulation of the N-methyl-D-aspartate receptor has a trophic effect on differentiating cerebellar granule cells. Neurosci. Lett. 87:1988;80-86.
4. Bazzett T.J., Becker J.B., Kaatz K.W., Albin R.L. Chronic intrastriatal dialytic administration of quinolinic acid produces selective neural degeneration. Exp. Neurol. 120:1993;177-185.
5. Beal M.F., Kowall N.W., Ellison D.W., Mazurek M.F., Swartz K.J., Martin J.B. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature. 321:1986;168-171.
6. Beal M.F., Ferrante R.J., Swartz K.J., Kowall N.W. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J. Neurosci. 11:1991;1649-1659.
7. Boddeke H.M., Wiederfold K.H., Palacios J.M. Intracerebroventricular application of competitive and non-competitive NMDA antagonists induce similar effects upon rat hippocampal electroencephalogram and local cerebral glucose utilization. Brain Res. 585:1992;177-183.
8. Bull G., Oderfeld-Nowak B. Standardization of the radiochemical assay of choline acetyltransferase and a study of the activation of the enzymes in rabbit brain. J. Neurochem. 18:1971;935-941.
9. Curtis D.R., Watkins J.C. Acidic amino acids with strong excitatory actions on mammalian neurons. J. Physiol. (London). 166:1963;1-4.
10. Davies P., Katzman R., Terry R.D. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia. Nature. 288:1980;279-280.
11. Figueredo-Cardenas G., Anderson K.D., Chen Q., Veenman C.L., Reiner A Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats. Exp. Neurol. 129:1994;37-56.
12. Fonnum F. Glutamate: a neurotransmitter in mammalian brain. J. Neurochem. 42:1984;1-11.
13. Foster A.C., Jr. Whetsell W.O., Bird E.D., Schwarcz R. Quinolinic acid phosphoribosyltransferase in human and rat brain: activity in Huntington's disease and in quinolinate-lesioned rat striatum. Brain Res. 336:1985;207-214.
14. Halperin J.J., Heyes M.P. Neuroactive kynurenines in Lyme boreliosis. Neurology. 42:1992;43-50.
15. Heyes M.P., Rubinow D., Lane C., Markey S.P. Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. Ann. Neurol. 26:1989;275-277.
16. Heyes M.P., Papagapiou M., Leonard C., Markey S.P., Auer R.N. Brain and plasma quinolinic acid in profound insulin-induced hypoglycemia. J. Neurochem. 54:1990;1027-1033.
17. Heyes M.P., Swartz K.J., Markey S.P., Beal M.F. Regional brain and cerebrospinal fluid quinolinic acid concentrations in Huntington's disease. Neurosci. Lett. 122:1991a;265-269.
18. Heyes M.P., Brew B.J., Martin A. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29:1991b;202-209.
19. Heyes M.P. Quinolinic acid and inflammation. Ann. N.Y. Acad. Sci. 679:1993;211-216.
20. Lowry O.H., Rosenbrough N.J., Farr A.J., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
21. Moroni F., Lombardi G., Carla V., Lal S., Atone P., Nair N.P.V. Increase in the content of quinolinic acid in cerebrospinal fluid and frontal cortex of patients with hepatic failure. J. Neurochem. 47:1986;1667-1671.
22. Morris R.G., Anderson E., Lynch G.S., Bard M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D aspartate receptor antagonist, AP5. Nature. 319:1986;774-776.
23. Nadler J.V., Perry B.W., Cotman C.W. Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature. 271:1978;676-677.
24. Olney J.W., Ho O.L., Rhee V. Cytotoxic effects of acidic and sulphus containing amino acids on the infant mouse central nervous system. Exp. Brain Res. 14:1971;61-76.
25. Saito K., Crowly J.S., Markey S.P., Heyes M.P. A mechanism for increased quinolinic acid formation following acute systemic immune stimulation. J. Biol. Chem. 268:1993;15496-15503.
26. Schwarcz R., Whetsell W.O.Jr., Mangano R.M. Quinolinic acid: An endogenous metabolite that produces axon-sparing lesions in rat brain. Science. 219:1983;316-318.
27. Schwarcz R., Koehler C. Differential vulnerability of central neurons of the rat to quinolinic acid. Neurosci Lett. 38:1983;85-90.
28. Schwarcz R., Okuno E., White R.J., Bird E.D., Whetsell W.O.Jr. 3-Hydroxyanthranthranilate oxygenase activity is increased in the brains of Huntington's disease victims. Proc. Natl. Acad. Sci. USA. 85:1988;4079-4081.
29. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28:1977;897-916.
30. Susel Z., Engber T.N., Kuo S., Chase T.N. Prolonged infusion of quinolinic acid into rat striatum as an excitotoxic model of neurodegenerative disease. Neurosci. Lett. 121:1991;234-238.
31. Tamminga C.A., Tanimoto K., Kuo S., Beck M., Chase T.N. Central cholecystokinin octapeptide reduces glucose utilization in subcortical but not cortical rat brain. Eur. J. Pharmacol. 139:1987;237-241.
32. Whetsell W.O.Jr., Schwarcz R. The organotypic tissue culture model of corticostriatal system used for examining amino acid neurotoxity and its antagonism: studies on kainic acid, quinolinic acid and (-)2-amino-7-phosphonoheptanoic acid. J. Neural Transm. Suppl. 19:1983;53-63.
33. Whetsell W.O.Jr., Schwarcz R. Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci. Lett. 97:1989;271-275.
34. Whetsell W.O.Jr., Shapira N.A. Neuroexcitation, Excitotoxicity and Human Neurological Disease. Lab. Invest. 68:1993;372-387.
35. Wolfensberger M., Amsler U., Cuenod M., Foster A.C., Whetsell W.O.Jr., Schwarcz R. Identification of quinolinic acid in rat and human brain tissue. Neurosci Lett. 41:1983;247-252.
36. Yamada K., Fuji K., Nabeshima T., Kameyama T. Neurotoxicity induced by continuous infusion of quinolinic acid into the lateral ventricle in rats. Neurosci. Lett. 118:1990;128-131.